Methods for preventing and treating microbial infections by modulating transcription factors
CA 2489943 A1 · Owner: Paratek Pharmaceuticals, Inc. · Inventors: Levy, Stuart B.; Alekshun, Michael N.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The current invention is based, inter alia on the finding that the , transcription factor MarA and homologues of MarA, e.g. Rob and SoxS are , virulence factors. Accordingly, the invention discloses methods for screening compounds for their ability to modulate these virulence factors. The invention further describes methods for treating and preventing bacterial infections by modulating the expression and/or activity of transcription factors. In addition, the invention provides a method for identifying other virulence factors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 24, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.